We have located links that may give you full text access.
A Novel Type of Battery-Supercapacitor Hybrid Device with Highly Switchable Dual Performances Based on a Carbon Skeleton/Mg 2 Ni Free-Standing Hydrogen Storage Electrode.
ACS Applied Materials & Interfaces 2017 December 28
The sharp proliferation of high power electronics and electrical vehicles has promoted growing demands for power sources with both high energy and power densities. Under these circumstances, battery-supercapacitor hybrid devices are attracting considerable attention as they combine the advantages of both batteries and supercapacitors. Here, a novel type of hybrid device based on a carbon skeleton/Mg2 Ni free-standing electrode without the traditional nickel foam current collector is reported, which has been designed and fabricated through a dispersing-freeze-drying method by employing reduced graphene oxide (rGO) and multiwalled carbon nanotubes (MWCNTs) as a hybrid skeleton. As a result, the Mg2 Ni alloy is able to deliver a high discharge capacity of 644 mAh g-1 and, more importantly, a high cycling stability with a retention of over 78% after 50 charge/discharge cycles have been achieved, which exceeds almost all the results ever reported on the Mg2 Ni alloy. Simultaneously, the electrode could also exhibit excellent supercapacitor performances including high specific capacities (296 F g-1 ) and outstanding cycling stability (100% retention after 100 cycles). Moreover, the hybrid device can switch between battery and supercapacitor modes immediately as needed during application. These features make the C skeleton/alloy electrode a highly promising candidate for battery-supercapacitor hybrid devices with high power/energy density and favorable cycling stability.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app